25 May 2013
Keywords: Lundbeck, Merck & Co, Sycrest, Saphris, Genmab, CNS antibody, Antipsychotic
Article | 13 October 2010
Danish drugmaker Lundbeck A/S (LUND: DC) announced a worldwide commercialization agreement with US drugs giant Merck & Co (NYSE: ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
13 October 2010
12 October 2010
24 May 2013
© 2013 thepharmaletter.com